3D-Printing Final Guidance Clarifies Manufacturing Practice Expectations
Executive Summary
A year and a half after FDA issued a draft guidance to help makers of devices that rely on additive manufacturing, the agency has finalized the document in its bid to get ahead of the technology. The final guidance makes minor clarifications, but for the most is identical to the draft.
You may also be interested in...
US FDA Presents 3D Printing Scenarios To Spark Discussion, Lead To Future Guidance
The agency recently published a paper to spark discussions in the medtech industry on how to best regulate 3D printing of medical devices at points of care such a clinics and hospitals.
US FDA, NIST Join Forces To Improve Manufacturing, Prevent Drug And Device Shortages
The focus on innovative manufacturing will also include a new clearinghouse to share info about advanced manufacturing technology within the US agency’s device center.
FDA, NIST Join Forces To Improve Manufacturing, Quell Device Shortages
The focus on innovative manufacturing will also include a new clearinghouse to share info about advanced manufacturing technology within the US agency’s device center.